Roman Sniecinski

Professor

Emory University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Roman Sniecinski holds a position at Emory University School of Medicine in the United States. His research primarily focuses on coagulation, hemostasis, and the management of bleeding disorders in cardiac surgery, as evidenced by his recent articles. He has contributed significantly to advancing understanding in areas such as heparin resistance and the use of blood transfusions in patients with hereditary and acquired bleeding disorders.

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Bianca Rocca

ITALY

View details

Yuesong Hu

Harvard University

UNITED STATES

View details

Toshiaki Iba

JAPAN

View details

Jerrold Levy

Professor and CoDirector Cardiothoracic ICU

Duke University School of Medicine

UNITED STATES

View details

Kenichi Tanaka

Professor and Chair

University of Oklahoma Health Sciences Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Roman Sniecinski

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

“Finding a common definition of heparin resistance in adult cardiac surgery: Communication from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis”: reply

Finding a common definition of heparin resistance in adult cardiac surgery: communication from the ISTH SSC subcommittee on perioperative and critical care thrombosis and hemostasis

Reply to the letter to the editor regarding “Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis”

Use of coagulation factor concentrates and blood transfusion in cardiac surgery: a retrospective cohort study of adults with hereditary and acquired bleeding disorders

Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis

Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis

Detection of cellular traction forces via the force-triggered Cas12a-mediated catalytic cleavage of a fluorogenic reporter strand

Detection of cellular traction forces via the force-triggered Cas12a-mediated catalytic cleavage of a fluorogenic reporter strand

Evaluation of the efficacy and safety of amustaline/glutathione pathogen-reduced RBCs in complex cardiac surgery: the Red Cell Pathogen Inactivation (ReCePI) study-protocol for a phase 3, randomized, controlled trial

FEIBA Use in Neonatal Cardiac Surgery: A Risky Business That Needs Further Investigation

Mean distance from skin to epiglottis in parturients as measured by airway ultrasound

COVID‐19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid

COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography

Anticoagulation Monitoring for Perioperative Physicians

Validation of an admission coagulation panel for risk stratification of COVID-19 patients

Collaborators (5)

Bianca Rocca

Yuesong Hu

Toshiaki Iba

Jerrold Levy

Kenichi Tanaka

Make your next move.